Serum nm23-H1 Protein as a Prognostic Factor in Hematological Malignancies
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Leukemia & Lymphoma
- Vol. 43 (4) , 859-867
Abstract
A nondifferentiating mouse myeloid leukemia cell line produces differentiation-inhibiting factors. One of these factors was purified as a homologue of nm23. The nm23 gene was isolated as a metastasis-suppressor gene that exhibits low expression in high-level metastatic cancer cells. The nm23 gene was overexpressed in acute myelogenous leukemia (AML) cells and a higher level of nm23-H1 expression was correlated with a poor prognosis in AML. Multivariate analysis of putative prognostic factors revealed that elevated nm23-H1 mRNA levels significantly contributed to the prognosis of patients with AML. The overexpression of nm23-H1 was also observed in various hematological neoplasms. To use nm23 overexpression to determine the prognosis for lymphoma, we established an enzyme-linked immunosorbent assay (ELISA) technique to determine the serum level of nm23-H1 protein. This assay is far simpler than that used to determine nm23 mRNA by reverse transcriptase-polymerase chain reaction (RT-PCR). Using this system, we measured nm23-H1 protein levels in many hematological malignancies. Serum nm23-H1 levels were significantly higher in patients with all of the hematological neoplasms tested (AML, chronic myelogenous leukemia, acute lymphoblastic leukemia, (ALL) myelodysplastic syndrome (MDS) and malignant lymphomas) than in normal controls. An elevated serum nm23-H1 protein concentration predicted a poor outcome for AML and non-Hodgkin's lymphoma. Especially in diffuse large B-cell lymphoma (DLBCL), serum nm23-H1 protein levels were an important prognostic factor in planning an appropriate treatment strategy for DLBCL. The serum nm23-H1protein levels probably depend on the total mass of malignant cells overexpressing nm23-H1.Keywords
This publication has 40 references indexed in Scilit:
- The Human Nm23/Nucleoside Diphosphate KinasesJournal of Bioenergetics and Biomembranes, 2000
- A novel human nucleoside diphosphate (NDP) kinase, Nm23-H6, localizes in mitochondria and affects cytokinesisJournal of Cellular Biochemistry, 2000
- NME6: a new member of the nm23 /nucleoside diphosphate kinase gene family located on human chromosome 3p21.3Human Genetics, 1999
- A new human nm23 homologue (nm23‐H5) specifically expressed in testis germinal cells1FEBS Letters, 1998
- Decrease in Nucleoside Diphosphate Kinase (NDPK/nm23) Expression during Hematopoietic MaturationJournal of Biological Chemistry, 1998
- nm23 -H4, a new member of the family of human nm23 /nucleoside diphosphate kinase genes localised on chromosome 16p13Human Genetics, 1997
- Overexpression of DR-nm23, a protein encoded by a member of the nm23 gene family, inhibits granulocyte differentiation and induces apoptosis in 32Dc13 myeloid cells.Proceedings of the National Academy of Sciences, 1995
- Nm23/nucleoside diphosphate kinase: Toward a structural and biochemical understanding of its biological functionsBioEssays, 1995
- The humanNME2 gene lies within 18kb ofNME1 in chromosome 17Genes, Chromosomes and Cancer, 1993
- Evidence for a Novel Gene Associated With Low Tumor Metastatic PotentialJNCI: Journal of the National Cancer Institute, 1988